European Patent Appeals Board Rules for Transkaryotic
Serono filed a lawsuit against Transkaryotic in the District Court at The Hague in the Netherlands in February, alleging that Transkaryotic infringed a gene-activation patent related to its drug Replagal for Fabry disease, a rare genetic disorder.
However, the Technical Board of Appeals of the European Patent Office invalidated the patent held by Serono's subsidiary, Applied Research Systems ARS Holdings, N.V., Transkaryotic said...
Already a subscriber? Click here to login